Previous studies have shown that drug concentrations in blood can change during storage, especially at room temperature, but even labile drugs such as cocaine may be stable in dried blood spots (DBS). A new method has been developed for the analysis of hydrolytically labile drugs in blood spots on filter paper in order to assess their degradation during a storage period of one month. The drugs selected included flunitrazepam, temazepam, oxazepam, lorazepam, nitrazepam, diazepam, and cocaine. A Guthrie card 903 was spotted with 100 µL of blood containing the drugs at concentrations of 1000 ng/mL and left overnight to dry at room temperature. The filter paper was suspended in extraction buffer for 1 h with ultrasonication. Drugs were then extracted from the buffer by solid-phase extraction using Clean Screen ® columns and analyzed by liquid chromatography-tandem mass spectrometry. Method validation showed that all calibration curves were linear over the concentration range 5-200 ng/spot with correlation coefficients of 0.994-0.999. Interday and intraday precisions at three concentrations (10, 50, and 100 ng/spot) were 1.6-18.3% and 2.8-14.7%, respectively. Limits of detection were 0.29-0.74 ng/spot, and lower limits of quantitation were 0.99-2.46 ng/spot. Recoveries of all analytes were in the range 81-106%. DBS were stored in duplicate at room temperature, 4°C, and -20°C for up to one month. Degradation of the drugs in DBS at all storage conditions was less than for the corresponding liquid blood samples stored under similar conditions and more than 80% of each analyte could be recovered from the samples.
Introduction
The instability of drugs in biological samples during transportation and storage has been reported in previous studies and presents a challenge to the toxicologist, especially in the interpretation of the results of analysis (1) (2) (3) (4) (5) (6) (7) (8) . Degradation of drugs in the sample may occur as the result of three main types of reaction: reduction, oxidation, and hydrolysis (9, 10) . Drugs containing ester or amide groups in their structures, such as benzodiazepines and cocaine, are prone to degradation by hydrolysis, which is considered to be the most common drug degradation process (10) .
Benzodiazepines are central nervous system (CNS) depressants and are widely prescribed and abused. They are used as anxiolytics, sedatives, muscle relaxants and anticonvulsant drugs (11) (12) (13) (14) . The stability of benzodiazepines under different storage conditions has been studied and published reports indicate that they are of low stability when stored at ambient temperature or higher. Most benzodiazepines, except triazolobenzodiazepines, contain an amide group. The presence of an amide group facilitates hydrolysis reactions to produce aminobenzophenone derivatives, whereas the presence of a triazolo ring in the structure makes the compounds more resistant to hydrolysis (15) (16) (17) .
Cocaine is a widely abused CNS stimulant frequently detected in forensic cases (11, 12) . Cocaine is known to be unstable in blood samples and is rapidly degraded by enzymatic and chemical hydrolysis. The addition of a preservative with cholinesterase inhibitor activity can decrease enzymatic hydrolysis (7, 8) . Breakdown of cocaine in biological samples is attributed to the presence of the ester linkages in the structure.
The Guthrie card has been used for the collection of blood spots since 1960, when Dr. Guthrie used blood collected on filter paper to measure phenylalanine in newborns (18) . Dried blood spots (DBS) have also been used in therapeutic drug monitoring (19, 20) and diagnostic screening (21) (22) (23) (24) , as well as having been found suitable for drug analysis (25) (26) (27) (28) (29) and for reducing the breakdown of drugs (30) (31) (32) (33) .
The aims of this study were to validate a new method to determine and preserve hydrolytically labile drugs in dried blood spots on filter paper and to investigate the stability of these drugs in the blood spots during storage for one month at three different temperatures.
Solutions
0.1 M phosphate buffer (pH 6.0). One liter of solution was prepared by dissolving 1.7g of anhydrous disodium orthophosphate and 12.14 g of sodium dihydrogen orthophosphate monohydrate in 800 mL of deionized water. The pH was adjusted to 6 with 1 M potassium hydroxide, and the solution made up to volume with deionized water.
3 mM ammonium formate and 0.001% formic acid. This mobile phase was prepared by dissolving 0.189 g of ammonium formate in 800 mL deionized water followed by adding 10 µL of concentrated formic acid and making up to 1 L with deionized water.
Standard solutions of analytes. Working standards of unlabeled and labeled drugs were prepared by diluting 250 µL from each drug stock solution in 25 mL methanol to obtain a concentration of 1 µg/mL.
Preparation of blood samples
Packed human red blood cells which had passed their usable date were obtained from the Scottish National Blood Transfusion Service and were re-suspended in an equal volume of isotonic saline. The original blood collection used ethylene diamine tetra acetic acid (EDTA) as anticoagulant. The blood was spiked with all compounds to produce a final concentration of 1000 ng/mL of each analyte then mixed for 1 h to ensure the homogeneity of all analytes in the blood. After that, 100 µL of the spiked blood was spotted on the filter paper to produce 100 spots. The spot diameter was equal to 13 mm, and each spot contained 100 ng of each analyte.
The spotted samples were allowed to dry overnight at ambient temperature in the fume hood. Ten samples were analyzed on the first day to check on their homogeneity and treated as the first day concentrations. Then the prepared samples were divided into three groups and stored in sealed plastic bags to protect them from contamination and humidity and were then stored at three different temperatures (-20°C, 4°C, and room temperature). These storage temperatures were selected in relation to frequently used laboratory storage temperatures. The storage temperatures were monitored regularly during the period of the study. The times selected for analysis were at days 1 (day zero), 2, 4, 7, 14, and 30. The bags remained sealed until they were opened for processing of the DBS.
Extraction procedure
Extraction of the drugs from the DBS was carried out with three different solvents (methanol, ethyl acetate, and acetonitrile) and phosphate buffer (pH 6) to establish which would give the best recovery of the analytes. Phosphate buffer released hemoglobin and produced the best recoveries, so this was used in the rest of the study.
DBS samples were removed from the paper with a punch and added to 3.5 mL of phosphate buffer (pH 6) containing 100 µL of internal standard then vortex mixed and placed in an ultrasonic bath for 1 h to extract the drugs from the paper. The paper was discarded, and then the extract was centrifuged at 2500 rpm for 10 min.
Solid-phase extraction columns were conditioned with 3 mL of methanol, 3 mL water, and 2 mL buffer (pH 6). The sample extracts were then passed through the cartridges with no vacuum applied. The columns were washed with 2 mL water followed by 2 mL buffer/acetonitrile (80:20, v/v). The final column washing step was the addition of 2 mL of water followed by drying for 5 min. Elution of analytes was achieved using 3 mL of ethyl acetate/ammonia (98:2, v/v). The extracts were dried under a gentle stream of nitrogen, and then the residues were reconstituted in 100 µL of HPLC mobile phase, of which 20 µL was injected into the liquid chromatography-tandem mass spectrometry (LC-MS-MS) instrument.
The analysis was carried out in duplicate for each storage temperature.
Instrumentation
LC-MS-MS analysis was performed using a Thermo Finnigan LCQ Deca XP (Thermo Finnigan, San Jose, CA) equipped with a surveyor HPLC system. Chromatographic separation was achieved using a Gemini C18 column (150 mm × 2-mm i.d., 5-µm particle size) fitted with guard column (4 mm × 2 mm, 5 µm) with the same column packing. The mobile phase was a mixture of 3 mM aqueous ammonium formate solution containing 0.001% formic acid and acetonitrile starting at 65:35 (v/v) and changing to 10:90 (v/v) between 13 and 13.5 min. It was then held at 10:90 (v/v) between 13.5 and 16.5 min, then reset to the staring composition between 16.5 and 20 min.
Results and Discussion

Optimization of the extraction of analytes from DBS
Extraction of the analytes from the spots was tested using three different solvents and an aqueous buffer. Phosphate buffer (pH 6) showed the highest recovery compared to organic solvents (Table I) . Hemoglobin was also released from the spot when using buffer and consequently the buffer was used in the study to extract the drugs from the DBS followed by SPE.
Method validation
Linearity. The relationships between analyte concentrations and peak area ratios were linear over the range 5-200 ng/spot and the linear correlation coefficients (r 2 ) values were better than 0.99 for all analytes (Table II) .
Limit of detection (LOD) and lower limit of quantitation (LLOQ).
Limits of detection were calculated using equations 1 and 2. where Y B is the intercept, S B is the standard error of the regression line, and m is the gradient. LOD values for all analytes were 0.29-0.74 ng/spot, and LLOQ values were 0.99-2.46 ng/spot (Table II) . These statistically determined limits were higher than those determined empirically.
Recovery. Recoveries of analytes were determined at three concentrations (10, 50 and 100 ng/spot, n = 5) using equation 5.
Recovery (%) = (peak-area ratio of extracted standard/peak-area ratio of unextracted standard) × 100
Equation 5 The recoveries of all analytes were in the range 81-106% as shown in Table III .
Intraday and interday precision. The intraday and interday precisions were determined at three concentrations (10, 50, and 100 ng/spot, n = 5).
As shown in Table IV , the method showed good precision and the relative standard deviations (RSD %) for intra-and interday precision were in the range 1.6-18.3% and 2.8-14.7%, respectively, which are considered to be acceptable (34) .
Stability
The stability of the analytes was determined at three different storage temperatures by measuring the drug content remaining in DBS (in duplicate) after storing for periods of up to one month and comparing with the starting amount of 100 ng/spot. The residual drug amounts for a 1-month period are shown in Figure 1 .
All analytes were found to be stable at -20°C, and changes in the concentrations over a storage period of one month were less than 10%. Dehydration of the samples on the filter paper minimized the hydrolysis of drugs which are liable to this type of degradation and so the stability of the drugs in DBS was enhanced compared to liquid blood samples.
After storage for one month at refrigerator temperature, flunitrazepam, temazepam, oxazepam, lorazepam, nitrazepam, diazepam, and cocaine concentrations decreased by 9%, 6%, 6.5%, 6%, 4.6%, 4%, and 11%, respectively, from the original concentrations at day zero.
At room temperature, flunitrazepam and temazepam concentrations decreased by 15%, and oxazepam and lorazepam decreased by 12% and 11%, respectively. The nitrazepam concentration decreased by 15.5% from the original concentration after one month of storage, whereas diazepam concentration decreased by 12.3% and cocaine by 19.9%. (7) 68 (10) 78 (11) 100 (5) * Phosphate buffer pH 6. The influence of storage temperature on the stability of drugs in DBS, as shown in Figure 1 was much less than when the drugs are stored in whole blood specimens (35, 36) .
Conclusions
A validated method that can be used for the quantitative analysis of drugs in small volumes of blood contained in dry blood spots has been developed. The DBS technique provides a suitable procedure for the storage and analysis of samples in forensic toxicology because they are easy to handle, transport and to store in the laboratory, even in the absence of refrigeration, which can be a problem in some countries. It permits the analysis of a small volume of sample and as a result frequent collection of blood samples from donors is possible. In addition, the test analytes chosen for this study were drugs that are known to be rapidly degraded in biological samples, and these were preserved when stored on paper, instead of adding the usual preservatives and anticoagulants. For some drugs, the addition of preservatives is not recommended as they may accelerate the degradation of these drugs (e.g., organophosphorus pesticides) (37), whereas anticoagulants are not recommended for other drugs as they can increase their concentrations (e.g., morphine) (38) . The DBS technique is therefore recommended as an additional procedure to be used in conjunction with conventional methods for preserving unstable drugs from decomposition and for avoiding potential errors in interpretation of analytical results resulting from the addition or absence of preservatives and anticoagulants.
The water present in blood samples plays a very important role in hydrolysis reactions as an active reagent that cleaves drug molecules. The use of filter paper to store samples resulted in enhancement of drug stability because of the dehydration of the sample on the card and consequent minimization of enzymatic and chemical hydrolysis of the drugs. Further work is currently in progress to cover storage periods of up to one year, but the technique also needs to be validated for other drug groups. 
